Seikagaku Corporation - Tokyo Stock Exchange Code: 4548
Seikagaku Corporation (Seikagaku) is a medical device company.
It develops and manufactures medical devices, and pharmaceuticals specifically related to glycoconjugates.
The company provides ethical drugs, pharmaceutical intermediates and biological research and diagnostics in the field of glycoscience. Its major products include intra-articular injections for improving joint functions; cross-linked hyaluronate hydrogel for knee osteoarthritis; and ophthalmic surgical aids. It also offers endotoxin-detecting reagents and bulk products including hyaluronic acid and sodium chondroitin sulfate.
The company operates across Asia, North America and Europe. Seikagaku is headquartered in Tokyo, Japan.
The company focuses on thoughtfully designed innovations, based on extensive consumer insight, to meet the needs of hospitals and clinics.
Seikagaku envisages establishing its position through the development of innovative products and enhancement of existing ones, internal development, strong partner relationships and strategic collaborations.